What to Look for in a COVID-19 Testing and Vaccination Partner

August 5, 2021

Planning to offer COVID-19 testing or vaccinations? You need an experienced partner. Here’s what to look for in a COVID-19 testing and vaccination... Read More

July 29, 2021

The latest offering from Color makes it easy to deliver on-demand or scheduled COVID-19 testing to workgroups and... Read More

May 26, 2021

After more than a year of disruption, getting students back to campus is a top priority for university administrators. In our COVID-19 work with higher education institutions, we’ve seen a whirlwind of nearly constant change over the... Read More

February 2, 2021

Today, biotech manufacturer and supplier New England Biolabs (NEB) and Color, a leading health technology company committed to advancing public health, announced their partnership providing weekly COVID-19 testing to NEB’s US-based... Read More

Color’s software facilitating significant increase in COVID-19 testing in California

October 30, 2020

Today, California Governor Gavin Newsom announced Burlingame-based health technology company Color will provide software infrastructure and test collection kits in support of the collaboration between PerkinElmer Health Sciences, Inc. and the California Department of Public... Read More

Antigen vs. PCR-based COVID-19 Testing: Pros & Cons

October 20, 2020

As the COVID-19 pandemic continues, new questions around different types of tests and testing models are arising – and the best choice for any given population isn’t always clear. Antigen testing and rapid point-of-care tests are facing new questions about their accuracy,... Read More

Awareness to Action: Navigating breast cancer care during the COVID-19 pandemic

October 8, 2020

During the COVID-19 pandemic, Breast Cancer Awareness Month looks a little different. For many people, routine cancer screenings have been postponed or canceled, due to concerns about the risks associated with attending in-person appointments. As always, Color observes this... Read More

19 organizations from the healthcare community unite to form COVID-19 testing industry consortium

October 1, 2020

Widespread accurate testing for SARS-CoV-2, the virus that causes COVID-19, is one critical aspect needed to limit the spread of the disease. By creating the COVID-19 Testing Industry Consortium, 19 organizations from the healthcare industry have joined forces with a goal to... Read More

With New EUA, Color’s COVID-19 self-collection kit enables public health and large private labs to increase access to testing

September 16, 2020

Color, a leading health technology company committed to advancing public health, received an emergency use authorization (EUA) from the U.S. Food and Drug Administration that enables CLIA-certified laboratories designated by Color to use its self-swab COVID-19 collection kit for... Read More

How we built our COVID-19 intake product in a week

September 14, 2020

In March, Color quickly mobilized our diagnostic genetics testing infrastructure to respond to the COVID-19 pandemic. While Color’s lab was developing our lab tests and validation, the product and engineering teams started to untangle what testing flows are needed in a... Read More

Modeling SARS-CoV-2 outbreaks in workplaces, universities, and other congregate settings

August 6, 2020

The SARS-CoV-2 pandemic has upended the way we work, teach, and socialize. As the pandemic continues, institutions are solving for how to bring people back on-site safely. One of the most important aspects of returning on-site is ensuring that adequate steps are taken to protect... Read More

USC Student Health begins campus-wide COVID-19 testing with Color

July 30, 2020

University of Southern California Student Health announces that it will expand COVID-19 testing as part of its overall testing strategy to help keep students, faculty and staff safe on its campuses.  Beginning in August, the university will begin ramping up to a minimum of 500... Read More

Color receives emergency use authorization for unmonitored COVID-19 testing technology

July 27, 2020

Today, Color, a leading health technology company based in the Bay Area, announced it has received an Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration to offer COVID-19 testing without clinical monitoring. The Color test now supports unmonitored... Read More

COVID-19 symptoms analysis and clustering methods

July 16, 2020

Color recently published a press release highlighting key results from an analysis of data from over 30,000 individuals who completed a Color COVID-19 test. The press release highlighted that the majority of individuals who test positive reported mild or no symptoms, and only a... Read More

New COVID-19 test data: Majority of people who test positive for COVID-19 have mild symptoms or are asymptomatic

June 18, 2020

Today Color is releasing new data from its COVID-19 testing program that demonstrates the importance of widespread testing to reopen cities, universities, and businesses. Color has returned COVID-19 test results to more than 30,000 people, with 1.3% testing positive. The... Read More

The COVID-19 workforce testing plan that will help America reopen

May 11, 2020

As we start the long process of bringing America back to work, we are facing the reality that the conditions that enabled outbreaks to occur across the world remain virtually the same. The vast majority of the population is susceptible to contracting COVID-19, for which we have... Read More

Mobilizing Color’s infrastructure in response to the COVID-19 crisis

March 31, 2020

As the magnitude of the COVID-19 crisis became clear, we mobilized Color to contribute our clinical testing infrastructure and services to support the emergency response. Three weeks ago, Color began repurposing services that we have used to scale population genetics to increase... Read More

Novel Coronavirus: What are the facts?

February 6, 2020

Michael Doney MD, MS, MPH is Color’s Head of Medical Affairs. Before joining Color, Michael worked at the US Centers for Disease Control & Prevention (CDC), where he served as Associate Director, Preparedness & Response in the Division of Global Migration and... Read More